Supporting The Front Line of Our Freedom January 8, 2016 • admin • Working to better protect our military personnel from chemical nerve agent attack. Related News Exclusive worldwide license agreement signed with the University of California at San Diego for two new, novel oxime drug technologies. June 18, 2014 Data from two relevant animal models presented at the 2017 CounterACT meeting by Countervail CEO June 16, 2017
